Cargando…
Correction: Neamatallah et al. Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism. Molecules 2020, 25, 3031
Autores principales: | Neamatallah, Thikryat, El-Shitany, Nagla, Abbas, Aymn, Eid, Basma G., Harakeh, Steve, Ali, Soad, Mousa, Shaker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377013/ https://www.ncbi.nlm.nih.gov/pubmed/37570904 http://dx.doi.org/10.3390/molecules28155626 |
Ejemplares similares
-
Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism
por: Neamatallah, Thikryat, et al.
Publicado: (2020) -
Antidiabetic effects of novel ellagic acid nanoformulation: Insulin-secreting and anti-apoptosis effects
por: Harakeh, Steve, et al.
Publicado: (2020) -
Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity
por: Hu, S, et al.
Publicado: (2017) -
Antioxidant, Anti-inflammatory, and Antiulcer Potential of Manuka Honey against Gastric Ulcer in Rats
por: Almasaudi, Saad B., et al.
Publicado: (2016) -
The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community
por: El-Shitany, Nagla A., et al.
Publicado: (2021)